What does Innate Pharma SA do?

Innate Pharma SA is a public company in the Biological Products, (No Diagnostic Substances) industry, incorporated in I0. It is registered with the SEC under CIK 0001598599 and trades on OTC under the ticker IPHYF.

How many SEC filings has Innate Pharma SA made?

Innate Pharma SA has filed 310 documents with the SEC since 2014. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Innate Pharma SA

IPHYF OTC CIK: 0001598599 Biological Products, (No Diagnostic Substances) Inc. in I0

View on SEC.gov →

Overview All Filings Financials Insiders

Recent Filings

All 310 filings →

Form	Description	Date
6-K	6-K	Mar 26, 2026
6-K	6-K	Mar 19, 2026
6-K	6-K	Feb 18, 2026
6-K	6-K	Jan 7, 2026
6-K	6-K	Dec 22, 2025
6-K	6-K	Dec 11, 2025
6-K	6-K	Nov 28, 2025
6-K	6-K	Nov 17, 2025
6-K	6-K	Nov 13, 2025
6-K	6-K	Nov 10, 2025

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Innate Pharma SA. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0001598599
Ticker: IPHYF
Exchange: OTC
Incorporated: I0
First Filing: 2014
Total Filings: 310